首页> 外文期刊>BMC Public Health >Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine
【24h】

Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine

机译:乌克兰HIV阳性女性在怀孕期间和产后第一年坚持抗逆转录病毒疗法

获取原文
       

摘要

Background Poor adherence to antiretroviral therapy (ART) is associated with HIV disease progression and, during pregnancy, increased mother-to-child transmission risk. In Ukraine, access to combination ART is expanding but data on adherence are scarce. Methods Cross-sectional surveys of HIV-positive women were conducted i) at delivery (on antenatal ART adherence) and ii) during the first year postpartum (on ART adherence in the preceding four weeks). Factors associated with a score ≤11 on the self-report Case Adherence Support Evaluation (CASE) index or ≥1 self-reported missed dose were assessed using Fisher’s exact test. Results Of 185 antenatal participants and 102 postnatal participants, median ages were 27.5 and 29.5?years respectively: 28% (50/180) and 27% (26/98) reported an unplanned pregnancy, and 13% (24/179) and 17% (17/98) an illicit drug-use history (excluding marijuana). One quarter (49/180 antenatally, 27/101 postnatally) screened positive for depression. The proportion reporting ‘low’ ART-related self-efficacy (i.e. unable to do ≥1/5 ART-taking activities) was 20% (28/141) antenatally and 17% (11/66) postnatally. Antenatally, 14% (95% CI 10-21%) had a CASE score ≤11 and 35% (95% CI 28-42%) reported missing ≥1 dose. Factors associated with a CASE score ≤11 were unplanned pregnancy (25% (12/48) vs. 11% (13/120) where planned, p?=?0.03) and living with extended family (23% (13/57) vs. 10% (12/125) living with partner/alone, p?=?0.04). Self-report of ≥1 missed dose antenatally was additionally associated with younger age (p?=?0.03) and lower self-efficacy (50% (14/28) reported ≥1 missed dose vs. 28% (30/108) of those with high self-efficacy, p?=?0.04). Of 102 postnatal participants, 8% (95% CI 4-15%) had a CASE score ≤11 and 31% (95% CI 22-41%) reported ≥1 missed dose. Of 11 women with low self-efficacy, 3 (27%) had a CASE score ≤11 compared with 3/55 (5%) of those with high self-efficacy (p?=?0.05). Current smokers more commonly reported ≥1 missed dose postnatally (50% (13/26) vs. 25% (18/72) of non-smokers, p?=?0.03). Conclusions Our results highlight unmet needs for counselling and support. We identify some groups at risk of poor ART adherence, including women with markers of social vulnerability and those with low ART-related self-efficacy, who may benefit from targeted interventions.
机译:背景技术抗逆转录病毒疗法(ART)依从性差与HIV疾病的进展以及在怀孕期间母婴传播风险增加有关。在乌克兰,抗逆转录病毒疗法组合的使用正在扩大,但依从性的数据却很少。方法对艾滋病毒呈阳性的妇女进行横断面调查,包括:i)分娩时(产前抗逆转录病毒治疗依从性)和ii)产后第一年(前四周抗逆转录病毒依从性)。使用Fisher精确检验评估与自我报告病例坚持支持评估(CASE)指数得分≤11或自我报告漏诊剂量≥1的因素。结果185名产前参与者和102名产后参与者的中位年龄分别为27.5和29.5岁:28%(50/180)和27%(26/98)报告计划外怀孕,13%(24/179)和17岁%(17/98)属于非法药物使用史(不包括大麻)。四分之一(产前49/180,产后27/101)筛查抑郁呈阳性。报告的与ART相关的“低”自我效能(即不能进行≥1/ 5的ART活动)的比例在产前为20%(28/141),在产后为17%(11/66)。在产前,有14%(95%CI 10-21%)的CASE得分≤11,有35%(95%CI 28-42%)的CASE得分≥1。与CASE得分≤11相关的因素是计划外怀孕(25%(12/48)比计划中的11%(13/120),p?=?0.03)和大家庭(23%(13/57))与10%(12/125)与伴侣/单独生活时相比,p?=?0.04)。产前自我报告≥1个剂量的失误还与年龄更小(p?=?0.03)和较低的自我效能感(50%(14/28)报告≥1剂量而不是28%(30/108)的失效率自我效能感较高的人,p≥0.04)。在102名产后参与者中,有8%(95%CI 4-15%)的CASE得分≤11,而31%(95%CI 22-41%)的CASE分数≥1。在11位自我效能感低下的女性中,有3位(27%)的CASE得分≤11,而在自我效能感高的女性中有3/55(5%)(p?=?0.05)。当前吸烟者更普遍地报告产后漏服≥1(非吸烟者占50%(13/26),而非吸烟者占25%(18/72),p = 0.03)。结论我们的结果强调了未得到满足的咨询和支持需求。我们确定了一些抗逆转录病毒依从性较差的人群,包括具有社会脆弱性标志的妇女和抗逆转录病毒疗法相关的自我效能低下的人群,这些人群可能会从有针对性的干预措施中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号